← SynDRA
2-MERCAPTOETHANESULFONIC ACID
SynDRA canonical compound SYN0021771 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Mechanism of action | antioxidant |
| Indication | hemorrhagic cystitis |
| Disease area | urology |
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- PDE4A
- PTGS1
- ACHE
- MAOA
- MMP9
- MMP1
- MC5R
- MC4R
- MC3R
- MAPT
- MAPK3
- MAPK14
- MAPK1
- LCK
- NPY2R
- KDR
- KDM4E
- KCNH2
- HTR6
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- HRH3
- HRH2
- HRH1
- NPY1R
- OPRD1
- NR3C1
- SIGMAR1
- TDP1
- TBXAS1
- TBXA2R
- TACR2
- TACR1
- SLCO1B3
- SLCO1B1
- SLC6A4
- SLC6A3
- SLC6A2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Protective Agents
- antioxidant
ATC classes
- V03A · ALL OTHER THERAPEUTIC PRODUCTS
- R05C · EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS
Cross-references
Synonyms
- IFEX/MESNEX KIT
- IFOSFAMIDE/MESNA KIT
- MESNA
- MESNEX
- Mesnex
- mesna
- mercaptoethanesulfonic acid
- reduced coenzyme M
- Mesna free acid
- Coenzyme m
- Sodium 2-mercaptoethanesulfonate
- Uromitexan
- Mitexan
- Mistabron
- Mesnum
- 2-Mercaptoethanesulfonic acid sodium salt
- Mistabronco
- Sodium 2-mercaptoethane sulfonate
- Ethanesulfonic acid, 2-mercapto-, monosodium salt
- Coenzyme M sodium salt
- sodium;2-sulfanylethanesulfonate
- 2-Mercaptoethanesulfonate, sodium
- 2-mercaptoethanesulfonic acid sodium
- Sodium 2-mercaptoethanesulfonate;Mesnum
- sodium 2-sulfanylethane-1-sulfonate
- D-7093
- NR7O1405Q9
- NSC 113891
- NCGC00181166-01
- Mesnum [INN-Latin]
- SMR000059219
- CAS-19767-45-4
- Natrium 2-mercaptoethansulfonat
- CCRIS 3712
- 2-Mercaptoethane sulfonate sodium
- Sodium 2-Mercaptoethanesulphonate
- EINECS 243-285-9
- UNII-NR7O1405Q9
- 2-Mercapto-ethan-sulfonsaeure, natrium-salz
Reported adverse events
- Asthenia
- Constipation
- Cough
- Dizziness
- Fatigue
- Flushing
- Headache
- Hypersensitivity
- Hypotension
- Insomnia
- Nausea
- Pain
Look up 2-MERCAPTOETHANESULFONIC ACID in the interactive SynDRA portal →